Plasma Pro‐C3 (N‐terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|2|429-437

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.2, 2015-02, pp. : 429-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association between C-Reactive Protein Levels and N-Terminal Pro-B-Type Natriuretic Peptide in Pre-Dialysis Patients

By  

Nephron Clin Pract, Vol. 97, Iss. 4, 2004-11 ,pp. : c125-c130

Karger

Access to resources Recommend Favorite

Fibrosis progression in patients treated for hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2624-2625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1127-1134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Fibrosis progression in patients treated for hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2625-2625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brain Natriuretic Peptide and N-Terminal proBNP in Chronic Haemodialysis Patients

By  

Nephron Clin Pract, Vol. 103, Iss. 4, 2006-05 ,pp. : c162-c172

Karger

Access to resources Recommend Favorite